Intelligent Commercial and Market Access Strategy
With a deep understanding of the global market and payer landscape, Veranex can better align the value you deliver with stakeholder needs including clinicians, payers, patients, and health systems.
What We Offer
Our global panel of payer and health technology assessment leaders, combined with a rigorous understanding of the clinical and economic burden of disease, allows us to build strategic reimbursement road maps that address everything from coding to policy, pricing, and evidence development. With our unique implementation expertise, our team is with you every step of the way, delivering the tools that help you communicate and capture value.
Let us assist you in evaluating your intended market and develop health economic, reimbursement, and
overall business strategies to drive commercial viability for any service or product for Medtech.
Innovation Strategy and Portfolio Prioritization
Growth through innovation is often a top priority, but ensuring that the process delivers competitive advantage is challenging. The demands of value-based healthcare put even more pressure on innovation as stakeholders demand increased quality while controlling costs. Meeting this challenge requires identifying real clinical and economic unmet needs and the types of evidence that will be required to support adoption and reimbursement. We focus on value assessment and creation that helps companies achieve sustained competitive advantage.
Market Assessment and Strategy
It’s one thing to identify a market opportunity, but another to execute and win in today’s marketplace. We embed our product development and market access expertise into market opportunity assessment and forecasting. We understand that payer acceptance, health economic value, and evidence investment requirements are the building blocks for robust business cases. Our proprietary analytics enable us to deliver real-world insights that inform actionable market and growth strategies.
Pricing, Reimbursement, and Market Access
Payers and health systems are demanding more from novel drugs, devices, and diagnostic technologies than ever before. We have a deep understanding of the global payer landscape including financial risks at hospitals and within healthcare systems to better align the value our clients deliver with the expectations of reimbursement and funding stakeholders. We excel at building strategic reimbursement roadmaps that address everything from coding, to policy, pricing, and evidence development.
Health Economics, Outcomes Research, and Value Communication
Payers, clinicians, regulators, and investors are increasingly assessing the value of innovation in terms of results —both clinical and economic. We develop robust health economic analysis and use communication tools that deliver success in an environment where proving clinical and economic value to payers and providers is essential for success.
M&A and Partnerships
Today’s medical technology M&A (Mergers and Acquisitions) environment is extremely competitive. Innovators must move quickly to identify opportunities, evaluate them, and close transactions that will drive real growth. We help clients anticipate market changes to create sustained value and gain an edge over the competition. Our expertise is built on the realities of payer coverage and pricing in a value-based healthcare environment. We identify and prioritize opportunities, offering you a much clearer picture of transaction opportunities and risks.
Delivering the right treatment to the right patient at the right time depends on a complex mix of analytics and insights. Our capabilities in global market access, commercial strategy, and data and advanced analytics puts us in a unique position to support medicine innovators in developing effective commercialization strategies and globally scalable solutions needed to drive routine patient access to appropriate diagnostic technologies and resulting intervention.
We Are Better Together
We help clients unlock the value of medical devices, diagnostics, and biopharmaceuticals that have the potential to transform patient care and improve health outcomes. Our multi-disciplinary global teams bring deep industry and functional expertise on a range of perspectives. We work in a uniquely collaborative model to deliver results that help our clients grow.
33 Arch Street
Boston MA 02110
Room 503 Building B WenDing Road
Shanghai XuHui District
Leipziger Platz 11
Berlin DE-BE 10117